Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06310642 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain Sickness
A Phase 4 study, sponsored by CHRISTUS Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT06310642 is a Phase 4 study that has completed, run by CHRISTUS Health. The registered enrollment target is 30 participants.
The verdict
NCT06310642, a Phase 4 study, has completed, sponsored by CHRISTUS Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
A field-based trial was conducted to determine if oral prochlorperazine demonstrates efficacy in the prophylactic treatment of AMS, and/or decreases the incidence of the symptoms of acute mountain sickness including headache, GI symptoms, fatigue and dizziness based on data collected in the Lake Louise AMS score.
Interventions
- DRUG Diphenhydramine
- OTHER Immediate descent from altitude.
- DRUG Prochlorperazine 10 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-05-20 |
| Est. Completion | 2023-03-13 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06310642
The ClinicalTrials.gov registry entry for NCT06310642 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CHRISTUS Health, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Diphenhydramine is the first listed.
NCT06310642 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06310642 about?
NCT06310642 is a clinical study titled "Efficacy of Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain Sickness". A field-based trial was conducted to determine if oral prochlorperazine demonstrates efficacy in the prophylactic treatment of AMS, and/or decreases the incidence of the symptoms of acute mountain sickness including headache, GI symptoms, fatigue and dizziness based on data collected in the Lake Lou...
What is the current status of trial NCT06310642?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2021-05-20. Estimated completion is 2023-03-13.
What interventions are being tested in trial NCT06310642?
The interventions under investigation include: Diphenhydramine (DRUG), Immediate descent from altitude. (OTHER), Prochlorperazine 10 mg (DRUG).
Who is sponsoring clinical trial NCT06310642?
This trial is sponsored by CHRISTUS Health, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.